The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Open accessAbstract
Perivascular microglia activation is a hallmark of inflammatory demyelination in multiple sclerosis (MS), but the mechanisms underlying microglia activation and specific strategies to attenuate their activation remain elusive. Here, we identify fibrinogen as a novel regulator of microglia activation and show that targeting of the interaction of fibrinogen with the microglia integrin receptor Mac-1 (alpha(M)beta(2), CD11b/CD18) is sufficient to suppress experimental autoimmune encephalomyelitis in mice that retain full coagulation function. We show that fibrinogen, which is deposited perivascularly in MS plaques, signals through Mac-1 and induces the differentiation of microglia to phagocytes via activation of Akt and Rho. Genetic disruption of fibrinogen-Mac-1 interaction in fibrinogen-gamma(390-396A) knock-in mice or pharmacologically impeding fibrinogen-Mac-1 interaction through intranasal delivery of a fibrinogen-derived inhibitory peptide (gamma(377-395)) attenuates microglia activation and suppresses relapsing paralysis. Because blocking fibrinogen-Mac-1 interactions affects the proinflammatory but not the procoagulant properties of fibrinogen, targeting the gamma(377-395) fibrinogen epitope could represent a potential therapeutic strategy for MS and other neuroinflammatory diseases associated with blood-brain barrier disruption and microglia activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Fibγ390-396A mice have reduced clinical scores and microglia activation in EAE. (A) Clinical scores of MOG35-55–immunized mice. Fibγ390-396A mice (blue triangles; n = 29) show statistically significant lower clinical scores (*, P < 0.01) than FibγWT control mice (black squares; n = 28). (B) Individual clinical scores from Fibγ390-396A and FibγWT mice on days 20 (average clinical score, 3.3 ± 0.22 for FibγWT [n = 19] vs. 2.1 ± 0.32 for Fibγ390-396A [n = 20]; P < 0.01) and 31 after immunization (average clinical score, 2.8 ± 0.25 for FibγWT [n = 15] vs. 1.5 ± 0.23 for Fibγ390-396A [n = 20]; P < 0.001). (C) Histological analysis of spinal cord sections stained with hematoxylin/eosin revealed increased inflammation in the FibγWT mice versus the Fibγ390-396A mice. (D) Survival curve of Fibγ390-396A and FibγWT mice after MOG35-55 immunization. Fibγ390-396A had a greater survival rate than the FibγWT mice. (E) Rotarod analysis of Fibγ390-396A and FibγWT mice on day 13. Fibγ390-396A significantly outperformed their wild-type counterparts in a behavioral test designed to assess motor skill function. n = 7 mice per group. **, P < 0.05. (F) Increased activation of IsoB4+ cells in FibγWT mice as compared with Fibγ390-396A mice. Bar, 58 μm. Data are represented as the mean clinical score and are mean ± SEM.](https://figures.cochat.ai/paper-figures/a0547757dbd947b08e158d353bae9525/the-fibrin-derived-377-395-peptide-inhibits-microglia-activation-and-suppresses-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fggγ390–396A knock-in mice, which express fully coagulable fibrinogen that selectively lacks the CD11b receptor binding site (Adams et al., 2007; Flick et al., 2004).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Adams et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Moreover, in vivo live imaging showed that BBB disruption provokes the immediate and focal activation of microglia (7).”
BackgroundNew Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“For peptide- recognizing integrin receptors, such as the RGD-recognizing αvβ3 and α5β1 integrins, both the peptide itself and antibodies against the peptide may inhibit integrin-mediated biological eff ects (49-52).”
BackgroundInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“The CD11c+ perivascular dendritic cells are responsible for the presentation of myelin antigens (58, 59).”
Background(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.x5001-0 · Cited by 769
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Self-citationExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 6×
“Prior studies have shown that genetic ablation of CD11b+ microglia (3) or antibodies against CD11b, such as M1/70 (48), reduce symptoms in EAE.”
BackgroundResultInfluentialEpitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694 · cited 1×
“The CD11c+ perivascular dendritic cells are responsible for the presentation of myelin antigens (58, 59).”
BackgroundLehnardt, S., Lachance, C., Patrizi, S., Lefebvre, S., Follett, P. L., Jensen, F. E., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02478.2002 · Cited by 689
Blood-brain barrier disruption in multiple sclerosis
Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms965oa · Cited by 638
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
Lassmann, H., Brück, W., & Lucchinetti, C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01909-2 · Cited by 627
Self-citationKERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578
Flick, M. J., Du, X., Witte, D. P., Jiroušková, M., Soloviev, D. A., Busuttil, S. J., Plow, E. F., & Degen, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20741 · Cited by 450
Self-citationHerwald, H., Cramer, H., Mörgelin, M., Russell, W., Sollenberg, U., Norrby-Teglund, A., Flodgaard, H., Lindbom, L., & Björck, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00057-1 · Cited by 375
Altieri, D. C., Bader, R., Mannucci, P. M., & Edgington, T. S. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.5.1893 · Cited by 356
Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
Languino, L. R., Plescia, J., Duperray, A., Brian, A. A., Plow, E. F., Geltosky, J. E., & Altieri, D. C. (1993) · Cell · doi:10.1016/0092-8674(93)90367-y · Cited by 343
CR3: a general purpose adhesion-recognition receptor essential for innate immunity
Ehlers, M. R. W. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00299-9 · Cited by 323
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., & Probert, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316
Self-citationMeyer, A., Auernheimer, J., Modlinger, A., & Kessler, H. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947740 · Cited by 291
Brocke, S., Piercy, C., Steinman, L., Weissman, I. L., & Veromaa, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6896 · Cited by 282
CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen.
Loike, J. D., Sodeik, B., Cao, L., Leucona, S., Weitz, J. I., Detmers, P. A., Wright, S. D., & Silverstein, S. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.1044 · Cited by 279
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
Coller, B. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119307 · Cited by 263
Roles of PI3Ks in leukocyte chemotaxis and phagocytosis
Stephens, L., Ellson, C., & Hawkins, P. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00311-3 · Cited by 258
Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
Karnezis, T., Mandemakers, W., McQualter, J. L., Zheng, B., Ho, P. P., Jordan, K. A., Murray, B. M., Barres, B., Tessier-Lavigne, M., & Bernard, C. C. A. (2004) · Nature Neuroscience · doi:10.1038/nn1261 · Cited by 230
Carson, M. J. (2002) · Glia · doi:10.1002/glia.10145 · Cited by 227
Brosnan, C. F., Bornstein, M. B., & Bloom, B. R. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.2.614 · Cited by 219
Molecular determinants of acute inflammatory responses to biomaterials.
Tang, L., Ugarova, T. P., Plow, E. F., & Eaton, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118549 · Cited by 207
Fibrin Inhibits Peripheral Nerve Remyelination by Regulating Schwann Cell Differentiation
Akassoglou, K., Yu, W.-M., Akpinar, P., & Strickland, S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00617-7 · Cited by 195
Self-citationMicroglia and multiple sclerosis
Jack, C., Ruffini, F., Bar‐Or, A., & Antel, J. P. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20482 · Cited by 193
Vos, C. M. P., Geurts, J. J. G., Montagne, L., van Haastert, E. S., Bö, L., van der Valk, P., Barkhof, F., & de Vries, H. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.012 · Cited by 188
Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis
Claudio, L., Raine, C. S., & Brosnan, C. F. (1995) · Acta Neuropathologica · doi:10.1007/bf00296505 · Cited by 182
Brain-specific deletion of neuropathy target esterase/ swisscheese results in neurodegeneration
Akassoglou, K., Malester, B., Xu, J., Tessarollo, L., Rosenbluth, J., & Chao, M. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401030101 · Cited by 176
Self-citationSiao, C.-J., Fernandez, S. R., & Tsirka, S. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03234.2003 · Cited by 169
Zhou, H., Lapointe, B. M., Clark, S. R., Zbytnuik, L., & Kubes, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8103 · Cited by 166
van der Laan, L. J. W., Ruuls, S. R., Weber, K. S., Lodder, I. J., Döpp, E. A., & Dijkstra, C. D. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00110-5 · Cited by 165
KWON, E. E., & PRINEAS, J. W. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199411000-00010 · Cited by 160
The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion
Barnett, M. H., Henderson, A. P. D., & Prineas, J. W. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1304rr · Cited by 158
Fibrin mechanisms and functions in nervous system pathology.
Adams, R. A., Passino, M. A., Sachs, B. D., Nuriel, T., & Akassoglou, K. (2004) · PubMed · doi:10.1124/mi.4.3.6 · Cited by 151
Self-citationRecognition of Fibrinogen by Leukocyte Integrins
Ugarova, T. P., & Yakubenko, V. P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03523.x · Cited by 148
Identification of a Novel Recognition Sequence for Integrin αMβ2 within the γ-chain of Fibrinogen
Ugarova, T. P., Solovjov, D. A., Zhang, L., Loukinov, D., Yee, V. C., Medved, L. V., & Plow, E. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22519 · Cited by 148
Rotshenker, S. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:1:65 · Cited by 143
Tran, E. H., Hardin‐Pouzet, H., Verge, G. M., & Owens, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00215-9 · Cited by 134
Akassoglou, K., Adams, R. A., Bauer, J., Mercado, P., Tseveleki, V., Lassmann, H., Probert, L., & Strickland, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303859101 · Cited by 128
Self-citationImmunohistochemical study of vascular injury in acute multiple sclerosis.
Wakefield, A. J., More, L. J., Difford, J., & McLaughlin, J. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.2.129 · Cited by 127
Fibrin(ogen)-α M β 2 Interactions Regulate Leukocyte Function and Innate Immunity In Vivo
Flick, M. J., Du, X., & Degen, J. L. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901104 · Cited by 121
Self-citationCytoskeletal remodeling in leukocyte function
Fenteany, G., & Glogauer, M. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200401000-00004 · Cited by 118
Vassilev, T. L., Kazatchkine, M. D., Huyen, J. D. V., Mekrache, M., Bonnin, E., Mani, J. C., Lecroubier, C., Korinth, D., Baruch, D., Schriever, F., et al. (1999) · Blood · doi:10.1182/blood.v93.11.3624 · Cited by 116
Regulated Unmasking of the Cryptic Binding Site for Integrin αMβ2 in the γC-Domain of Fibrinogen
Lishko, V. K., Kudryk, B. J., Yakubenko, V. P., Yee, V. C., & Ugarova, T. P. (2002) · Biochemistry · doi:10.1021/bi026324c · Cited by 112
Paterson, P. Y. (1976) · PubMed · Cited by 110
Nervous System Pathology: The Fibrin Perspective
Akassoglou, K., & Strickland, S. (2002) · Biological Chemistry · doi:10.1515/bc.2002.004 · Cited by 85
Self-citationPhagocytosis and the microtubule cytoskeleton
Harrison, R. E., & Grinstein, S. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-142 · Cited by 76
Multiple sclerosis: trapped in deadly glue
Platten, M., & Steinman, L. (2005) · Nature Medicine · doi:10.1038/nm0305-252 · Cited by 74
Influence of Calcium Ion on the Binding of Fibrin Amino Terminal Peptides to Fibrinogen
Laudano, A. P., & Doolittle, R. F. (1981) · Science · doi:10.1126/science.7209542 · Cited by 73
Ugarova, T. P., Lishko, V. K., Podolnikova, N. P., Okumura, N., Merkulov, S. M., Yakubenko, V. P., Yee, V. C., Lord, S. T., & Haas, T. A. (2003) · Biochemistry · doi:10.1021/bi034057k · Cited by 64
Xiao, B., Bai, X., Zhang, G., & Link, H. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00264-6 · Cited by 63
Cross, A. H., & Raine, C. S. (1991) · PubMed · Cited by 42
A Novel Model of Demyelinating Encephalomyelitis Induced by Monocytes and Dendritic Cells
Furtado, G. C., Piña, B., Tacke, F., Gaupp, S., van Rooijen, N., Moran, T. M., Randolph, G. J., Ransohoff, R. M., Chensue, S. W., Raine, C. S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6871 · Cited by 42
Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats
Inoue, A., Koh, C.-S., Shimada, K., Yanagisawa, N., & Yoshimura, K. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00150-6 · Cited by 41
Modulation (Inhibition and Augmentation) of Complement Receptor-3-Mediated Myelin Phagocytosis
Reichert, F., Slobodov, U., Makranz, C., & Rotshenker, S. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0383 · Cited by 40
Bell, W. R., Ss, S., Martinez, J., & Nossel, H. L. (1978) · PubMed · Cited by 39
Seasholtz, T. M., Radeff‐Huang, J., Sagi, S. A., Matteo, R., Weems, J. M., Cohen, A. S., Feramisco, J. R., & Brown, J. H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02749.x · Cited by 33
Disease-modifying treatments in multiple sclerosis
Noseworthy, J. H., Miller, D., & Compston, A. (2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50020-3 · Cited by 29
Ishikawa, M., Jin, Y., Guo, H., Link, H., & Xiao, B. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500308 · Cited by 18
Yura, M., Takahashi, I., Terawaki, S., Hiroi, T., Kweon, M., Yuki, Y., & Kiyono, H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00278-x · Cited by 16
Research works printed but not linked: 6
- 2001, Trends Mol. Med., 7, 115
- 2004, Mol. Interv., 4, 163
- 1976, Fed. Proc., 35, 2428
- 1978, J. Lab. Clin. Med., 91, 592
- 2002, Biol. Chem., 383, 37
- 1991, Am. J. Pathol., 139, 1401
Cited by
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Self-citationWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Metadata
- Authors
- Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K.
- Affiliations
- University of California San Diego (US)
- Medical University of Vienna (AT)
- University of Cincinnati (US)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-03-05
- Volume
- 204
- Issue
- 3
- Pages
- 571-582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2137908
- OpenAlex
- W2142424019
- Cited by
- 335
- References
- 72
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 19 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS052189, P30NS047101, R01NS051470)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- fibrinogen, microglial activation, Mac-1, CD11b/CD18, multiple sclerosis, experimental autoimmune encephalomyelitis, inflammatory demyelination, Akt signaling, Rho GTPase signaling, blood-brain barrier disruption, neuroinflammation
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Female, Fibrin, Fibrinogen, Mice, Inbred C57BL, Molecular Sequence Data, Peptide Fragments, Macrophage-1 Antigen, Microglia, Multiple Sclerosis, Relapsing-Remitting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.